A PHASE II TRIAL OF THE MULTI-TARGETED KINASE INHIBITOR LENVATINIB (E7080) IN ADVANCED MEDULLARY THYROID CANCER (MTC)

被引：0

作者：

Schlumberger, M. ^{[1
]}

Jarzab, B. ^{[2
]}

Cabanillas, M. E. ^{[3
]}

Robinson, B. ^{[4
]}

Furio, P. ^{[5
]}

Ball, D. W. ^{[6
]}

McCaffrey, J. C. ^{[7
]}

Newbold, K. ^{[8
]}

Allison, R. ^{[9
]}

Martins, R. G. ^{[10
]}

Licitra, L. ^{[11
]}

Shah, M. H. ^{[12
]}

Bodenner, D. L. ^{[13
]}

Elisei, R. ^{[14
]}

Burmeister, L. A. ^{[15
]}

Funahashi, Y.

Sellecchia, R.

Andresen, C.

O'Brien, J. P.

Sherman, S. ^{[16
]}

机构：

[1] Inst Gustave Roussy, Roussy, France

[2] Ctr Onkol Inst Gliwice, Gliwice, Poland

[3] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[4] Royal N Shore Hosp, Sydney, NSW, Australia

[5] Azienda Osped Univ Senese, Turin, Italy

[6] Johns Hopkins Med Inst, Tokyo, Japan

[7] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[8] Royal Marsden Hosp, London, England

[9] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia

[10] Seattle Canc Care Alliance, Seattle, WA USA

[11] Ist Nazl Tumori, Milan, Italy

[12] Ohio State Univ, Sch Med, Columbus, OH 43210 USA

[13] Univ Arkansas, Fayetteville, AR 72701 USA

[14] Azienda Osped Univ Pisana, Pisa, Italy

[15] Univ Minnesota, Minneapolis, MN 55455 USA

[16] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

来源：

ANNALS OF ONCOLOGY | 2012年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：35 / 36

页数：2